Clinical trial
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced…
NCT00359606 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00359606 |
|---|---|
| Title | 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer |
| Official title | Phase I Trial of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug, Other |
| Interventions | 5-Fluoro-2-Deoxycytidine (FdCyd), Laboratory Biomarker Analysis, Pharmacological Study, Tetrahydrouridine (THU) |
| Enrollment | 58 |
| Start date | Apr 1, 1999 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Aug 2, 2006 |
| Last update posted | May 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: